The SLC10A2 gene helps the small intestine take bile acids back up after they have helped digest fats. If it does not work well, bile acids may be lost in stool instead of recycled, which can lead to ongoing diarrhea, belly cramps, trouble absorbing fats, and low levels of vitamins A, D, E, and K. In medicine, this gene is important because it supports the normal recycling system between the intestine and liver.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate activities in the body. Some genes hold the instructions for producing proteins, which do much of the work inside cells. Other genes mainly control when certain processes happen, where they take place, and how strongly they operate. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To explore this topic in more detail, you can read more in the LearnHub.
Overview
SLC10A2Gene function
What if the gene works
The SLC10A2 gene helps the small intestine take bile acids back up after meals. This recycling supports fat digestion and helps your body maintain a steady bile acid supply.
Risk
What if the gene does not work
Variants in the SLC10A2 gene can cause primary bile acid malabsorption, leading to chronic watery diarrhea and sometimes poor fat absorption. Milder and more severe variants may change when symptoms start and how marked they are.
Treatment
What does that mean for your treatment
No SLC10A2-specific treatment or drug-choice approach is currently established for people with pathogenic variants in the SLC10A2 gene. The SLC10A2 gene is an active drug target in other conditions, and medicines that block this transporter, such as odevixibat, are used or studied for some cholestatic liver diseases and itch, rather than for SLC10A2-related deficiency itself.
Gene function
What if the gene works
Every day, your body needs to reuse bile acids so meals with fat can be handled efficiently. In the last part of the small intestine, the SLC10A2 gene helps move these digestive salts back into the body instead of letting them leave in stool. This helps keep digestion running in a steady cycle.
The SLC10A2 gene helps cells in the lower small intestine take bile acids back in after they have helped with digestion. It uses sodium, a natural body salt, to pull these molecules across the cell surface.
By recovering bile acids, this gene supports the normal recycling loop between the intestine and liver. This keeps a ready supply available so the body can reuse them during future meals.
This transport process helps maintain the bile acid pool your body depends on to handle dietary fat and absorb vitamins A, D, E, and K. Understanding how the SLC10A2 gene supports bile acid recycling in the small intestine helps explain its role in everyday digestion.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including variation in appearance, metabolism, or how the body responds to environmental factors. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some situations, however, a variant can change how a gene functions more significantly and may contribute to, or cause, a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC10A2 gene can weaken the transporter protein, make it unstable, or stop it from reaching the intestinal cell surface, which reduces bile acid uptake. This is the main way SLC10A2 gene variants affect bile acid transport. Some variants are milder and leave partial activity, while more severe variants can nearly abolish transport. In people with disease causing variants, lower remaining activity is often linked to earlier or more persistent features of bile acid malabsorption.
How variants are linked to conditions
Rare harmful variants in the SLC10A2 gene cause primary bile acid malabsorption, an inherited condition linked to ongoing diarrhea, urgency, bloating, and poor weight gain. In people with SLC10A2 gene variants linked to bile acid malabsorption, symptoms may begin in infancy, childhood, or adulthood. Finding a pathogenic variant in this gene can confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widespread in the general population. Most do not have a direct effect on health and instead represent normal human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors contribute. In some situations, though, a single well characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the SLC10A2 gene. For many living with a harmful SLC10A2 change, risk is mainly linked to the genetic change itself rather than clear lifestyle factors, so personal guidance from a doctor or genetic counselor can be helpful.
Inheritance of SLC10A2 variants
SLC10A2-related conditions are inherited in an autosomal recessive pattern. In practical terms, SLC10A2 gene inheritance usually means a child needs to inherit one disease-causing variant from each parent to be affected. Parents who each carry one variant are usually unaffected themselves, and with each pregnancy there is a 25% chance the child will inherit both variants, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither variant. This pattern applies equally to sons and daughters.
What does my SLC10A2 result mean for my family?
Changes in the SLC10A2 gene are linked to a condition that is usually passed down in a recessive way, so close relatives may also be carriers even if they have no symptoms. Brothers and sisters could have the same condition or carry the same gene change. For family members, the main question is often whether they might also carry the change, especially when planning children.
Genetic information
Genetic testing
How you find out about variants
To find out about variants in the SLC10A2 gene, genetic testing for SLC10A2 variants usually uses DNA from a blood or saliva sample. A lab reads the gene’s DNA code and compares it with the usual pattern to identify variants that may help explain an inherited condition.
When should I consider getting a genetic test?
Consider testing for changes in the SLC10A2 gene if there is a family history of a rare inherited problem absorbing bile acids, or if someone has ongoing watery diarrhea, poor weight gain, or low vitamin levels starting early in life and other causes have been ruled out. Testing can help confirm the cause.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it reveals depends on the condition and the specific type of variant involved. Over time, factors such as lifestyle, environment, age, and medical history also shape how the body functions. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, moves, or responds to a drug, so the same treatment may work better for one person than for another. These differences are common and can influence how much benefit a medicine gives or how sensitive someone is to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medications. It studies relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes affect either how strongly a drug works or how the body processes it. This information can support treatment decisions that are more informed and more individualized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the SLC10A2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice, so questions about side effects, new symptoms, or how well a treatment is working are best discussed with your doctor. Research on the SLC10A2 gene has explored possible links with bile acid-related medicines, but this is not part of routine care.
History
SLC10A2 entered the genetics literature in the late 1990s, when researchers identified and cloned the gene responsible for a known bile salt transport system in the small intestine. Initially understood only through visible traits, later recognized as tied to a specific gene, this work linked older physiology studies to a defined stretch of DNA. The gene was also named ASBT, short for apical sodium dependent bile acid transporter, and that name still appears in many research papers. From these first observations, research expanded steadily. Later studies connected rare inherited variants in the SLC10A2 gene with bile acid malabsorption, helping clinicians match long standing digestive symptoms with an underlying genetic cause.